References
- Falck-YtterYFrancisCWJohansonNAPrevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest2012141e278Se325S22315265
- ErikssonBIBorrisLCFriedmanRJRivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplastyN Engl J Med20083582765277518579811
- LassenMRAgenoWBorrisLCRivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplastyN Engl J Med20083582776278618579812
- TurpieAGGLassenMRDavidsonBLRivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialLancet20093731673168019411100
- TurpieAGGLassenMRErikssonBIRivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studiesThromb Haemost201110544445321136019
- KakkarAKBrennerBDahlOEExtended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialLancet2008372313918582928
- TurpieAGGHaasSKreutzRA non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustmentThromb Haemost20141119410224154549
- RosencherNBonnetMPSesslerDISelected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategiesAnaesthesia2007621154116017924897
- TurpieAGGBauerKAErikssonBISteering Committees of the Pentasaccharide Orthopedic Prophylaxis StudiesFondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studiesArch Intern Med20021621833184012196081
- RodgersAWalkerNSchugSReduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trialsBr Med J2000321149311118174
- European Medicines AgencyGuideline on Clinical Investigation of Medicinal Products for Prevention of Venous Thromboembolism (VTE) in Patients Undergoing High VTE-Risk Surgery2012 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/05/WC500127902.pdfAccessed January 20, 2016
- RaskobGEHirshJControversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgeryChest2003124379S385S14668421
- Bayer Pharma AGXarelto® (Rivaroxaban) Summary of Product Characteristics2015 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdfAccessed January 20, 2016
- GogartenWVandermeulenEVan AkenHEuropean Society of AnaesthesiologyRegional anaesthesia and antithrombotic agents: recommendations of the European Society of AnaesthesiologyEur J Anaesthesiol201027999101520890208
- RosencherNLlauJVMueckWLoeweABerkowitzSDHomeringMIncidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin)Acta Anaesthesiol Scand20135756557223336294
- MacfarlaneAJPrasadGAChanVWBrullRDoes regional anaesthesia improve outcome after total hip arthroplasty? A systematic reviewBr J Anaesth200910333534519628483
- PatelNKhakhaRGibbsJReview article: anti-embolism stockingsJ Orthop Surg (Hong Kong)20132136136424366800
- HoKMTanJAStratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patientsCirculation20131281003102023852609
- KakkosSKWarwickDNicolaidesANStansbyGPTsolakisIACombined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgeryJ Bone Joint Surg Br20129472973422628585
- WeberJCPEpidemiology of adverse reactions to nonsteroidal anti-inflammatory drugsRainsfordKDVeloGPAdvances in Inflammatory ResearchNew YorkRaven Press198417